Defining diabetes status using medication groups in Medicare data : Trends in prescribing diabetes medications to patients without a diabetes diagnosis over time
| Errataetall: |
ErratumIn: Diabetes Obes Metab. 2024 Apr 19;:. - PMID 38639059 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Diabetes, obesity & metabolism - 26(2024), 4 vom: 18. Apr., Seite 1548-1551 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Howell, Carrie R [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 05.03.2024 Date Revised 19.04.2024 published: Print-Electronic ErratumIn: Diabetes Obes Metab. 2024 Apr 19;:. - PMID 38639059 Citation Status MEDLINE |
|---|
| doi: |
10.1111/dom.15450 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367444305 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367444305 | ||
| 003 | DE-627 | ||
| 005 | 20240419232236.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240123s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/dom.15450 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1380.xml |
| 035 | |a (DE-627)NLM367444305 | ||
| 035 | |a (NLM)38253946 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Howell, Carrie R |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Defining diabetes status using medication groups in Medicare data |b Trends in prescribing diabetes medications to patients without a diabetes diagnosis over time |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.03.2024 | ||
| 500 | |a Date Revised 19.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumIn: Diabetes Obes Metab. 2024 Apr 19;:. - PMID 38639059 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Hypoglycemic Agents |2 NLM | |
| 700 | 1 | |a Zhu, Sha |e verfasserin |4 aut | |
| 700 | 1 | |a Malla, Gargya |e verfasserin |4 aut | |
| 700 | 1 | |a Carson, Gargya |e verfasserin |4 aut | |
| 700 | 1 | |a Cummings, Doyle |e verfasserin |4 aut | |
| 700 | 1 | |a Uddin, Jalal |e verfasserin |4 aut | |
| 700 | 1 | |a Levitan, Emily B |e verfasserin |4 aut | |
| 700 | 1 | |a Safford, Monika |e verfasserin |4 aut | |
| 700 | 1 | |a Cherrington, Andrea L |e verfasserin |4 aut | |
| 700 | 1 | |a Long, D Leann |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetes, obesity & metabolism |d 1999 |g 26(2024), 4 vom: 18. Apr., Seite 1548-1551 |w (DE-627)NLM111220432 |x 1463-1326 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2024 |g number:4 |g day:18 |g month:04 |g pages:1548-1551 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/dom.15450 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2024 |e 4 |b 18 |c 04 |h 1548-1551 | ||